Literature DB >> 20380484

Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.

Qin Meng1.   

Abstract

IMPORTANCE OF THE FIELD: Hepatotoxicity is the most frequent reason for the withdrawal of an approved drug from the market. Monolayer culture of hepatocyte in two-dimension, which is relatively inexpensive, convenient and easy to use, serves a traditional hepatocyte-based high-content screening for identifying hepatotoxic side effects of tested drugs. However, two-dimensional methods have their limitations in lack of insensitivity on reflection of drug hepatotoxicity. Three-dimensional (3D) cultures of hepatocytes in sandwich, spheroid and gel entrapment provide a microenvironment for high expression of liver-specific functions and are being proposed for prediction of drug hepatotoxicity. AREAS COVERED IN THIS REVIEW: This review addressed the reliability of 3D culture models on screening hepatotoxic drugs with particular emphasis on gel entrapment culture model due to its more systematic data on drug testing. WHAT THE READER WILL GAIN: The reader will gain a comprehensive understanding of the improved prediction efficacy of 3D culture models. TAKE HOME MESSAGE: Hepatocytes in 3D cultures, although in need of further standardization required by the throughput operation, show great potential in attempts to ensure the efficacy on prediction of drug hepatotoxicity.

Entities:  

Mesh:

Year:  2010        PMID: 20380484     DOI: 10.1517/17425251003674356

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  34 in total

Review 1.  Fibronectin: functional character and role in alcoholic liver disease.

Authors:  Razia S Aziz-Seible; Carol A Casey
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Electrotaxis of lung cancer cells in ordered three-dimensional scaffolds.

Authors:  Yung-Shin Sun; Shih-Wei Peng; Keng-Hui Lin; Ji-Yen Cheng
Journal:  Biomicrofluidics       Date:  2012-01-04       Impact factor: 2.800

3.  A novel 3D liver organoid system for elucidation of hepatic glucose metabolism.

Authors:  Yanhua Lu; Guoliang Zhang; Chong Shen; Korkut Uygun; Martin L Yarmush; Qin Meng
Journal:  Biotechnol Bioeng       Date:  2011-10-19       Impact factor: 4.530

4.  Long-term culture of primary hepatocytes: new matrices and microfluidic devices.

Authors:  Britta Burkhardt; Juan José Martinez-Sanchez; Anastasia Bachmann; Ruth Ladurner; Andreas K Nüssler
Journal:  Hepatol Int       Date:  2013-11-21       Impact factor: 6.047

5.  Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming.

Authors:  Shan Su; Cristina Di Poto; Rabindra Roy; Xuefeng Liu; Wanxing Cui; Alexander Kroemer; Habtom W Ressom
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-11

Review 6.  Organoids as an in vitro model of human development and disease.

Authors:  Aliya Fatehullah; Si Hui Tan; Nick Barker
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

Review 7.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

8.  Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions.

Authors:  Shan Su; Cristina Di Poto; Alexander H Kroemer; Wanxing Cui; Rabindra Roy; Xuefeng Liu; Habtom W Ressom
Journal:  Exp Cell Res       Date:  2019-09-09       Impact factor: 3.905

9.  In vitro models for liver toxicity testing.

Authors:  Valerie Y Soldatow; Edward L Lecluyse; Linda G Griffith; Ivan Rusyn
Journal:  Toxicol Res (Camb)       Date:  2012-11-23       Impact factor: 3.524

Review 10.  Concise review: the relevance of human stem cell-derived organoid models for epithelial translational medicine.

Authors:  Robert E Hynds; Adam Giangreco
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.